We've noticed that you're using an ad blocker

Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.

It's off now Dismiss How do I disable my ad blocker?
❌

How to disable your ad blocker for our site:

Adblock / Adblock Plus
  • Click on the AdBlock / AdBlock Plus icon on the top right of your browser.
  • Click “Don’t run on pages on this domain.” OR “Enabled on this site.”
  • Close this help box and click "It's off now".
Firefox Tracking Prevention
  • If you are Private Browsing in Firefox, "Tracking Protection" may casue the adblock notice to show. It can be temporarily disabled by clicking the "shield" icon in the address bar.
  • Close this help box and click "It's off now".
Ghostery
  • Click the Ghostery icon on your browser.
  • In Ghostery versions < 6.0 click “Whitelist site.” in version 6.0 click “Trust site.”
  • Close this help box and click "It's off now".
uBlock / uBlock Origin
  • Click the uBlock / uBlock Origin icon on your browser.
  • Click the “power” button in the menu that appears to whitelist the current website
  • Close this help box and click "It's off now".
  • ONCOLOGY
  • News
  • Blogs
  • Topics
  • Hematology
  • Image IQ
  • Podcasts
  • Videos
  • Slideshows
  • Conferences

Modern Medicine Network
  • Login
  • Register
Skip to main content
Modern Medicine Network
  • Login
  • Register
Menu
User
Home
  • ONCOLOGY
  • News
  • Blogs
  • Topics
  • Hematology
  • Image IQ
  • Podcasts
  • Videos
  • Slideshows
  • Conferences

SUBSCRIBE: Print / eNewsletter

Managed Care: To Live and Die in LA

  • Stephen Lemkin, MD
Jan 1, 1996
Volume: 
5
Issue: 
1

In Los Angeles, the future seems to arrive a little sooner than
in the rest of the country. The defense-based economy has crashed
and burned, shifting hundreds of thousands of employees into managed
care plans, mostly HMOs.

Nervously clutching our ASCO abstracts in our axillae, medical
oncologists here are knee deep in the results. By the painful
but simple mechanism of full risk capitation contracts, the managed
care industry has reversed two decades of medical oncology practice
history--they think for the better, but we're not so sure. How
did this come about?

Arguably, medical oncology did not exist until the early 1970s
(the first Boards were in 1973) when the combination chemotherapy
theories of Cooper, DeVita, and, later, Einhorn required sophisticated
management of drug protocols and their side effects. Prior to
that time, internists and surgeons were comfortable handling single
agents, and oncology was really a surgical subspecialty.

As it grew in the 1970s and 1980s (the "money is no object"
era in medicine), medical oncology evolved a practice paradigm
of benevolent excess. We used vast permutations of combination
chemotherapy, both empirically and systematically, in hopes of
eradicating, or at least palliating, the sufferings of common
cancers.

The limited success of most of these programs has not, in general,
caused a reassessment of purpose but, contrarily, has accelerated
ultra-high-dose therapies, requiring the development of disturbingly
expensive modalities and drugs to counter the ever-worsening symptoms
of vomiting, myelosuppression, and infection.

As long as fee-for-service held out on the private practice side,
and government research grants on the academic side, all was well.
However, those who viewed the situation from both a cost and an
outcome perspective questioned whether the confusing variability
in management of specific disease sites, and the lack of persuasive
evidence that one treatment was really better than another, meant
a bit of self-indulgent chaos.

Industry cannot and will not pay any longer, so it invented "managed
care." While traditional medical oncology was based on a
physician-patient compact for as much treatment as wanted by both,
for as long as either could tolerate it, managed care now means
as little treatment as possible, for as small a price as possible.

Pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • next ›
  • last »

Resource Topics rightRail

  • Resource Topics
  • Partner Content
Breast Cancer
Lung Cancer
Prostate Cancer
Colorectal Cancer
Melanoma
Cutaneous T-Cell Lymphomas: Mycosis Fungoides and Sézary Syndrome
3 Keys to Success in the Oncology Care Model

Current Issue

Oncology Vol 32 No 4
Apr 15, 2018 Vol 32 No 4
Digital Edition
Subscribe
Connect with Us
  • Twitter
  • Facebook
  • LinkedIn
  • RSS
Modern Medicine Network
  • Home
  • About Us
  • Advertise
  • Advertiser Terms
  • Privacy statement
  • Terms & Conditions
  • Editorial & Advertising Policy
  • Editorial Board
  • Contact Us
Modern Medicine Network
© UBM 2018, All rights reserved.
Reproduction in whole or in part is prohibited.